Molecular signature alteration reveals the Gata2-L359V mutation as a driver for the increment of GMPs and monocytosis in BCR/ABL-induced CML model. The gene discussed is GATA2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.